This company has been marked as potentially delisted and may not be actively trading. Histogenics (HSGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HSGX vs. SMTI, LAKE, INGN, AVR, ZJYL, MLSS, NTRB, APT, RBOT, and SPAIShould you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Sanara MedTech (SMTI), Lakeland Industries (LAKE), Inogen (INGN), Anteris Technologies Global (AVR), Jin Medical International (ZJYL), Milestone Scientific (MLSS), Nutriband (NTRB), Alpha Pro Tech (APT), Vicarious Surgical (RBOT), and Safe Pro Group Inc. Common Stock (SPAI). Histogenics vs. Sanara MedTech Lakeland Industries Inogen Anteris Technologies Global Jin Medical International Milestone Scientific Nutriband Alpha Pro Tech Vicarious Surgical Safe Pro Group Inc. Common Stock Sanara MedTech (NASDAQ:SMTI) and Histogenics (NASDAQ:HSGX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk. Which has higher valuation and earnings, SMTI or HSGX? Sanara MedTech has higher revenue and earnings than Histogenics. Sanara MedTech is trading at a lower price-to-earnings ratio than Histogenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$91.57M2.95-$4.30M-$1.34-22.68HistogenicsN/AN/A-$8.64M-$0.79-1.18 Do analysts recommend SMTI or HSGX? Sanara MedTech currently has a consensus price target of $49.50, suggesting a potential upside of 62.88%. Given Sanara MedTech's stronger consensus rating and higher possible upside, equities research analysts clearly believe Sanara MedTech is more favorable than Histogenics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Histogenics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SMTI or HSGX more profitable? Histogenics has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.71%. Sanara MedTech's return on equity of -19.86% beat Histogenics' return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% Histogenics N/A -34.96%18.40% Which has more volatility and risk, SMTI or HSGX? Sanara MedTech has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Comparatively, Histogenics has a beta of 3.1, meaning that its stock price is 210% more volatile than the S&P 500. Do insiders & institutionals believe in SMTI or HSGX? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 40.4% of Histogenics shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by company insiders. Comparatively, 19.7% of Histogenics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer SMTI or HSGX? Histogenics received 335 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 71.66% of users gave Histogenics an outperform vote while only 61.54% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes2461.54% Underperform Votes1538.46% HistogenicsOutperform Votes35971.66% Underperform Votes14228.34% Does the media prefer SMTI or HSGX? In the previous week, Sanara MedTech had 10 more articles in the media than Histogenics. MarketBeat recorded 10 mentions for Sanara MedTech and 0 mentions for Histogenics. Sanara MedTech's average media sentiment score of 0.49 beat Histogenics' score of 0.00 indicating that Sanara MedTech is being referred to more favorably in the media. Company Overall Sentiment Sanara MedTech Neutral Histogenics Neutral SummarySanara MedTech beats Histogenics on 9 of the 17 factors compared between the two stocks. Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSGX vs. The Competition Export to ExcelMetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$88.05M$9.40B$5.34B$8.30BDividend YieldN/A1.29%5.27%4.11%P/E Ratio-1.1820.6226.9819.59Price / SalesN/A63.69398.81136.58Price / CashN/A19.6738.3234.64Price / Book-93.085.056.774.50Net Income-$8.64M$284.66M$3.24B$248.60M Histogenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSGXHistogenicsN/A$0.93+1.8%N/A-46.8%$88.05MN/A-1.1849SMTISanara MedTech1.7645 of 5 stars$31.04-0.4%$49.50+59.5%-2.0%$275.88M$86.67M-31.3560LAKELakeland Industries4.6945 of 5 stars$19.85+2.1%$27.00+36.0%+4.8%$188.79M$167.21M-220.561,800News CoveragePositive NewsINGNInogen3.8581 of 5 stars$6.27+2.3%$7.00+11.6%-25.9%$168.58M$339.96M-2.791,030News CoverageAnalyst UpgradeAVRAnteris Technologies GlobalN/A$3.82-4.3%$16.50+331.9%N/A$137.76M$2.71M0.00138Gap DownZJYLJin Medical InternationalN/A$0.79-2.0%N/A-71.4%$123.67M$23.50M0.00245MLSSMilestone Scientific1.1178 of 5 stars$1.05+2.9%$1.25+19.0%+32.7%$82.30M$8.63M-15.0030Gap UpNTRBNutriband1.9224 of 5 stars$5.59-2.1%$13.00+132.6%+7.5%$62.35M$2.14M-7.8710News CoverageUpcoming EarningsAPTAlpha Pro TechN/A$4.41flatN/A-11.4%$47.91M$58.18M11.92120RBOTVicarious Surgical2.0187 of 5 stars$7.35-3.5%$9.25+25.9%-36.5%$43.59MN/A-0.713SPAISafe Pro Group Inc. Common StockN/A$2.85-4.4%N/AN/A$43.24M$2.17M-3.5211 Related Companies and Tools Related Companies SMTI Competitors LAKE Competitors INGN Competitors AVR Competitors ZJYL Competitors MLSS Competitors NTRB Competitors APT Competitors RBOT Competitors SPAI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSGX) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSGX Stock Free HSGX Stock Alerts